What is the proper dosage of Pepto Bismol (Bismuth subsalicylate) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pepto Bismol Dosing for Adults

Adults should take 2 chewable tablets (524 mg bismuth subsalicylate) every 30-60 minutes as needed, not exceeding 8 doses (4.2 g total) in 24 hours, with treatment duration limited to 2 days for diarrhea or acute gastrointestinal symptoms. 1

Standard Dosing Regimens

For Diarrhea

  • Take 2 chewable tablets every 30 minutes OR 4 chewable tablets every hour 1
  • Maximum: 8 doses (16 tablets total) in 24 hours 1
  • Duration: Do not use for more than 2 days 1
  • Drink plenty of clear fluids to prevent dehydration 1

For Upset Stomach, Heartburn, Indigestion, or Nausea

  • Take 2 chewable tablets every 30 minutes to 1 hour as needed 1
  • Same maximum daily limit applies: 8 doses in 24 hours 1

For H. pylori Eradication (Prescription Use)

  • Take 2 tablets or 2 capsules four times daily, 30 minutes before meals 2
  • Must be combined with tetracycline 500 mg four times daily (30 minutes after meals), metronidazole 500 mg four times daily, and a proton pump inhibitor twice daily 2
  • Duration: 14 days for optimal eradication rates 2

Safety Profile and Absorption

Salicylate Absorption

  • More than 90% of the salicylate component is absorbed systemically, reaching peak plasma concentrations 0.5-3 hours after ingestion 3, 4, 5
  • Peak plasma salicylate levels average 40.1 ± 17.3 mcg/mL after a 60 mL dose, well below toxic concentrations 4
  • The maximum daily dose (4.2 g bismuth subsalicylate) produces salicylate levels considerably below toxicity thresholds 3

Bismuth Absorption

  • Less than 0.5% of bismuth is absorbed from the gastrointestinal tract, with negligible systemic exposure 3, 6, 5
  • Peak plasma bismuth concentrations remain below 5.3 ng/mL with standard dosing, far below neurotoxic levels 5
  • Extended dosing up to 6 weeks produces mean blood bismuth concentrations of 16.1 ± 7.9 ng/g, well below neurotoxicity thresholds 3

Critical Safety Considerations

Duration Limits

  • For over-the-counter use, do not exceed 2 days of treatment 1
  • Extended dosing (3-4 weeks) is safe only under medical supervision for specific indications like H. pylori treatment 3

Important Administration Details

  • Fully chew tablets before swallowing for optimal effectiveness 1
  • Maintain adequate hydration, especially when treating diarrhea 1

Drug Interactions

  • Separate bismuth subsalicylate from fluoroquinolone antibiotics by at least 4 hours, as antacids significantly reduce fluoroquinolone absorption 7

Common Pitfalls to Avoid

  • Do not exceed 8 doses in 24 hours, as this increases salicylate exposure and potential toxicity risk 1, 3
  • Do not use for more than 2 days without medical consultation for acute symptoms 1
  • Avoid in patients with salicylate allergy or those taking other salicylate-containing medications due to additive effects 3, 4
  • Do not use in children under 12 years without physician guidance 1

References

Research

Bismuth subsalicylate: history, chemistry, and safety.

Reviews of infectious diseases, 1990

Research

Salicylate absorption from a bismuth subsalicylate preparation.

Clinical pharmacology and therapeutics, 1981

Guideline

Maalox Interactions and Special Populations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.